Alder BioPharmaceuticals to Host Conference Call to Discuss

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Alder BioPharmaceuticals to Host Conference Call to Discuss Third Quarter 2014 Financial and Operating Results

BOTHELL, Wash., Oct. 24, 2014 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ("Alder") (Nasdaq: ALDR ), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, autoimmune and inflammatory diseases, today announced that it will report its third quarter 2014 financial and operating results after the close of U.S. financial markets on Monday, November 3, 2014. Alder management will host a conference call and live audio webcast at 5:00 p.m. EST the same day.

The live call may be accessed by dialing (877) 430-4657 for domestic callers or (484) 756-4339 for international callers, and providing conference ID number 20836583. The webcast will be broadcast live on the investors section of Alder's website at www.alderbio.com and will be available for replay following the call for 30 days.

About Alder BioPharmaceuticals

Alder BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's ALD403 inhibits a well-validated molecule shown to trigger migraine attacks, calcitonin gene-related peptide (CGRP), and is now undergoing clinical testing. Alder plans to advance ALD403 into a Phase 2b trial for the treatment of chronic migraines in the fourth quarter of 2014 and a Phase 2b trial for frequent episodic migraines in the first half of 2015. Alder's second program, Clazakizumab, previously known as ALD518, is designed to block the pro-inflammatory cytokine IL-6 and has successfully completed a Phase 2b clinical study in rheumatoid arthritis. Alder's management team combines decades of industry experience with a proven track record for identifying and developing novel antibody therapeutics and enabling partners through the out-licensing of its technologies. For more information, please visit http://www.alderbio.com .

Forward Looking Statements

This press release contains forward-looking statements, including statements regarding the further development of ALD403, the initiation of future clinical trials and the potential of ALD403 and Clazakizumab to address the unmet medical needs of patients. All forward-looking statements included in this press release are based on our management's beliefs and assumptions and on information currently available to our management, and we assume no obligation to update any such forward-looking statements. Any or all of our forward-looking statements in this document may turn out to be wrong and actual events or results may differ materially. Our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks, uncertainties and other factors. In evaluating these statements, you should specifically consider various factors, including the risks outlined under the caption "Risk Factors" set forth in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 filed with the Securities and Exchange Commission (SEC) and other reports and filings we will make with the SEC from time to time. We caution investors that our business and financial performance are subject to substantial risks and uncertainties.

Media Contacts: David Schull or Andrea Flynn, Ph.D. Russo Partners (212) 845-4271 (646) 942-5631 Investor Relations Contact: Sarah McCabe Stern Investor Relations, Inc. (212) 362-1200

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 194

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 287

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 232

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 45

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 23

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 81

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
Envision and Tai Tam Put 45 MW Wind Bet to Work in Vietnam

Updated Category News Views 92

A wind site averaging 6.5 meters per second can look unremarkable on a map, yet that is precisely where equipment choices start separating serious developers from brochure merchants. Envision Energy and Vietnam's Tai Tam Group are taking that test on with the 45 MW Phuoc Dan wind project in Khanh Hoa Province. The arrangement follows five years of cooperation, but the...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 94

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 0

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading

Top 5 Most Recently Viewed Articles

TCL SunPower Global Teams Up with Energia Italia for Solar Expansion

Updated Category News Views 313

TCL SunPower Global and Energia Italia Join Forces TCL SunPower Global is thrilled to unveil a new strategic partnership with Energia Italia, designed to significantly enhance the availability of advanced solar technology. As a renowned distributor in the residential and commercial solar markets, Energia Italia will take on the responsibility of providing Italian...

Continue Reading
AHAM Challenges Colorado's Appliance Labeling in Court

Updated Category News Views 200

AHAM Takes Legal Action Against Appliance Labeling Law The Association of Home Appliance Manufacturers (AHAM) has filed a federal lawsuit in response to a new appliance labeling law in Colorado. This law specifically mandates that gas stoves display a warning label concerning alleged health risks. AHAM alleges that this directive infringes upon First Amendment rights,...

Continue Reading
Impact BioMedical Inc. Sets Price for Its Initial Public Offering

Updated Category News Views 63

Impact BioMedical Inc. Pricing for Initial Public Offering Announced Impact BioMedical Inc. (NYSE: IBO) has officially revealed the pricing details for its initial public offering, establishing itself as a significant presence in the healthcare and wellness sectors. The company plans to offer 1,500,000 shares of its common stock at a public offering price of $3.00 per...

Continue Reading
Local Bounti Navigates NYSE Compliance Notice, Eyes Growth

Updated Category News Views 151

Local Bounti Faces NYSE Compliance Challenge Local Bounti Corporation (NYSE: LOCL), a pioneer in innovative indoor agriculture, has recently received an important notice from the New York Stock Exchange (NYSE). The notice highlights that the company is currently not meeting certain listing standards set by the NYSE. This notification pertains to the Minimum Market...

Continue Reading
SCWorx Expands Partnership: Three-Year Renewal and Growth

Updated Category News Views 154

SCWorx Strengthens Healthcare Partnerships with Renewed Agreement New York, NY — In a significant move, SCWorx Corp. (NASDAQ: WORX), known for its innovative healthcare data management solutions, has successfully renewed its agreement with a vital healthcare partner for another three years. This decision marks a substantial endorsement of the value SCWorx delivers, as...

Continue Reading